share_log

HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $150 Price Target

Benzinga ·  Nov 18 20:26  · Ratings

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $150 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment